185 related articles for article (PubMed ID: 16836522)
1. Erysipeloid skin toxicity induced by gemcitabine.
Zustovich F; Pavei P; Cartei G
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):757-8. PubMed ID: 16836522
[No Abstract] [Full Text] [Related]
2. Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.
Kuku I; Kaya E; Sevinc A; Aydogdu I
J Eur Acad Dermatol Venereol; 2002 May; 16(3):271-2. PubMed ID: 12195570
[TBL] [Abstract][Full Text] [Related]
3. Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three cases.
Brandes A; Reichmann U; Plasswilm L; Bamberg M
Anticancer Drugs; 2000 Jan; 11(1):15-7. PubMed ID: 10757558
[TBL] [Abstract][Full Text] [Related]
4. Clinical, toxicological and pharmacological aspects of gemcitabine.
Guchelaar HJ; Richel DJ; van Knapen A
Cancer Treat Rev; 1996 Jan; 22(1):15-31. PubMed ID: 8625330
[No Abstract] [Full Text] [Related]
5. Erysipeloid rash: A rare adverse event induced by gemcitabine.
Ruiz-Casado A; Gutiérrez D; Juez I
J Cancer Res Ther; 2015; 11(4):1024. PubMed ID: 26881588
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine for lung cancer.
Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
[No Abstract] [Full Text] [Related]
7. Gemcitabine--a major advance?
Thomas A; Steward WP
Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
[No Abstract] [Full Text] [Related]
8. Gemcitabine in pre-treated advanced renal carcinoma: a feasibility study.
Casali M; Marcellini M; Casali A; Giuntini T; Galante E; Ferrone C
J Exp Clin Cancer Res; 2001 Jun; 20(2):195-8. PubMed ID: 11484974
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and vascular toxicity.
Muñoz A; Mañé JM; Rubio I; Fernández R; Fuente N; Barceló R; López Vivanco G
Lung Cancer; 2002 Aug; 37(2):229. PubMed ID: 12140148
[No Abstract] [Full Text] [Related]
10. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
Tempero MA; Brand R
Cancer; 1998 May; 82(9):1800-1. PubMed ID: 9576306
[No Abstract] [Full Text] [Related]
11. [Toxicity of intravesical gemcitabine in superficial bladder cancer treatment].
Beardo Villar P; Gamaza Martínez R; Gavira Moreno R
Farm Hosp; 2014 May; 38(3):249-51. PubMed ID: 24951911
[TBL] [Abstract][Full Text] [Related]
12. [Interstitial pneumonitis due to gemcitabine].
San José Ruiz B; Molas Ferrer G; Castro Rebollo P; Soy Muner D
Farm Hosp; 2012; 36(5):452-3. PubMed ID: 22871364
[No Abstract] [Full Text] [Related]
13. [Gemcitabine: Applications and perspectives].
Tumori; 1997; 83(5):877-80. PubMed ID: 9446252
[No Abstract] [Full Text] [Related]
14. Unusual response to gemcitabine in a case of peritoneal malignant fibrous histiocytoma.
Hitt R; Jimeno A; Castellano D; Cortés-Funes H
Anticancer Drugs; 2003 Sep; 14(8):663-4. PubMed ID: 14501390
[No Abstract] [Full Text] [Related]
15. Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma.
Lin CJ; Lim KH; Cheng YC; Chen HH; Wu CJ
Med Oncol; 2007; 24(4):455-7. PubMed ID: 17917099
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine and haemolytic-uraemic syndrome.
Ruiz I; Del Valle J; Gómez A
Ann Oncol; 2004 Oct; 15(10):1575-6. PubMed ID: 15367421
[No Abstract] [Full Text] [Related]
17. Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer.
Hiraya D; Kagohashi K; Sakamoto N; Kondo T; Satoh H
JOP; 2010 Mar; 11(2):186-8. PubMed ID: 20208333
[No Abstract] [Full Text] [Related]
18. Targetoid erythema surrounding multiple seborrheic keratoses induced by chemotherapy with gemcitabine.
Retrosi C; Vezzoni R; Conforti C; Corneli P; Magaton-Rizzi G; Zalaudek I; Di Meo N
Acta Dermatovenerol Alp Pannonica Adriat; 2019 Dec; 28(4):185-186. PubMed ID: 31855275
[TBL] [Abstract][Full Text] [Related]
19. Recurrent pseudocellulitis due to gemcitabine: underrecognized and underreported?
Dasanu CA; Bockorny B
J Oncol Pharm Pract; 2015 Oct; 21(5):377-9. PubMed ID: 24769519
[TBL] [Abstract][Full Text] [Related]
20. Use of gemcitabine (GEM) in advanced myelodysplastic syndromes.
Mario AD; Pagano L; Mele L; De Stefano V; Leone G
Ann Oncol; 2001 Oct; 12(10):1494. PubMed ID: 11762826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
